RT Journal Article
SR Electronic
T1 Tempo-spatial dynamics of COVID-19 in Germany – A phase model based on a pandemic severity indicator
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.17.23286084
DO 10.1101/2023.02.17.23286084
A1 Stabler, Martin
A1 Kuebart, Andreas
YR 2023
UL http://medrxiv.org/content/early/2023/02/23/2023.02.17.23286084.abstract
AB While pandemic waves are often analyzed on the national scale, they typically are not distributed evenly in space. This working paper employs a novel approach to analyze the tempo-spatial dynamics of the COVID-19 pandemic for the case of Germany. First, we base the analysis not just on the incidence of cases or mortality but employ a composite indicator of pandemic severity to gain a more robust understanding of the temporal dynamics of the pandemic. Second, we subdivide the pandemic during the years 0f 2020 and 2021 into fifteen phases, each with a coherent trend of pandemic severity. Third, we analyze the spatial patterns predominating in each phase. The resulting tempo-spatial phase model is used to identify explanatory factors for the tempo-spatial patterns identified in the analysis.Disclosures This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) with a research grant for the project Socio-spatial diffusion of COVID-19 in Germany. - 492338717Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) with a research grant for the project Socio-spatial diffusion of COVID-19 in Germany. - 492338717Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. All raw data are part of the public domain already.